Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.

@article{Razmy2004PredictorsOI,
  title={Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.},
  author={Ajmal Razmy and Anthony E Lang and Colin Michael Shapiro},
  journal={Archives of neurology},
  year={2004},
  volume={61 1},
  pages={97-102}
}
BACKGROUND Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and ropinirole hydrochloride have been reported to have sleep attacks without warning. OBJECTIVE To perform a systematic evaluation of excessive daytime sleepiness using standard polysomnographic techniques. DESIGN Two overnight studies and daytime sleep tests were performed on a prospective sample. Pathologic daytime sleep latency was indexed by a mean Multiple Sleep… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 69 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Similar Papers

Loading similar papers…